533 related articles for article (PubMed ID: 28256403)
41. Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation.
Cuscaden C; Ramsay SC; Prasad S; Goodwin B; Smith J
J Nucl Cardiol; 2021 Dec; 28(6):2845-2856. PubMed ID: 32385832
[TBL] [Abstract][Full Text] [Related]
42. Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).
Pilebro B; Arvidsson S; Lindqvist P; Sundström T; Westermark P; Antoni G; Suhr O; Sörensen J
J Nucl Cardiol; 2018 Feb; 25(1):240-248. PubMed ID: 27645889
[TBL] [Abstract][Full Text] [Related]
43. Regression of Myocardial
Papathanasiou M; Kessler L; Bengel FM; Jakstaite AM; Kersting D; Varasteh Z; Luedike P; Carpinteiro A; Herrmann K; Rassaf T; Rischpler C
J Nucl Med; 2023 Jul; 64(7):1083-1086. PubMed ID: 37290801
[TBL] [Abstract][Full Text] [Related]
44. Cardiac scintigraphy and echocardiography assessment in the diagnosis of transthyretin cardiac amyloidosis.
Del Carmen Mallón Araujo M; Casas EAJ; Casas CAJ; Monzonis MAM; Morell ÁR; Núñez VP
Int J Cardiovasc Imaging; 2024 Feb; 40(2):415-424. PubMed ID: 37943369
[TBL] [Abstract][Full Text] [Related]
45. Reduction in
Rettl R; Calabretta R; Duca F; Binder C; Kronberger C; Willixhofer R; Poledniczek M; Donà C; Nitsche C; Beitzke D; Loewe C; Auer-Grumbach M; Bonderman D; Kastl S; Hengstenberg C; Badr Eslam R; Kastner J; Bergler-Klein J; Hacker M; Kammerlander A
Amyloid; 2024 Mar; 31(1):42-51. PubMed ID: 37599395
[No Abstract] [Full Text] [Related]
46. False Positive in [ 99m Tc]Tc-DPD Scintigraphy for Cardiac Amyloidosis Due to Intravenous Iron Administration.
Rudolphi Solero T; Feriche Aragón M; Amrani Raissouni T; Delgado-García A; Cañada-Rodríguez MJ; Sanz Viedma S
Clin Nucl Med; 2024 Feb; 49(2):e65-e67. PubMed ID: 38048549
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis.
Treglia G; Glaudemans AWJM; Bertagna F; Hazenberg BPC; Erba PA; Giubbini R; Ceriani L; Prior JO; Giovanella L; Slart RHJA
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1945-1955. PubMed ID: 29687207
[TBL] [Abstract][Full Text] [Related]
48. Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis.
Tamarappoo B; Otaki Y; Manabe O; Hyun M; Cantu S; Arnson Y; Gransar H; Hayes SW; Friedman JD; Thomson L; Slomka P; Dey D; Vescio R; Patel J; Berman DS
J Nucl Cardiol; 2020 Feb; 27(1):28-37. PubMed ID: 31172386
[TBL] [Abstract][Full Text] [Related]
49. The role of serial
Ross JC; Hutt DF; Burniston M; Grigore SF; Fontana M; Page J; Hawkins PN; Gilbertson JA; Rowczenio D; Gillmore JD
Amyloid; 2022 Mar; 29(1):38-49. PubMed ID: 34704883
[TBL] [Abstract][Full Text] [Related]
50.
Khor YM; Cuddy SAM; Singh V; Falk RH; Di Carli MF; Dorbala S
Radiology; 2023 Feb; 306(2):e221082. PubMed ID: 36537896
[TBL] [Abstract][Full Text] [Related]
51. Non-cardiac uptake of technetium-99m pyrophosphate in transthyretin cardiac amyloidosis.
Sperry BW; Gonzalez MH; Brunken R; Cerqueira MD; Hanna M; Jaber WA
J Nucl Cardiol; 2019 Oct; 26(5):1630-1637. PubMed ID: 29344917
[TBL] [Abstract][Full Text] [Related]
52. AL-Type Amyloidosis Involving Stomach and Lungs in 99m Tc-DPD Bone Scan.
Lee Y; Yoo IR; O JH
Clin Nucl Med; 2022 Dec; 47(12):1059-1060. PubMed ID: 35835133
[TBL] [Abstract][Full Text] [Related]
53. Transthyretin Cardiac Amyloidosis as Diagnosed by 99mTc-PYP Scanning in Patients with Acute Heart Failure and Preserved Ejection Fraction.
Lo Presti S; Horvath SA; Mihos CG; Rajadhyaksha C; McCloskey V; Santana O
Crit Pathw Cardiol; 2019 Dec; 18(4):195-199. PubMed ID: 31725511
[TBL] [Abstract][Full Text] [Related]
54. Tc-99m-pyrophosphate scintigraphy for the diagnosis of ATTR cardiac amyloidosis: Comparison of quantitative and semi-quantitative approaches.
Régis C; Harel F; Martineau P; Grégoire J; Abikhzer G; Juneau D; Pelletier-Galarneau M
J Nucl Cardiol; 2020 Oct; 27(5):1808-1815. PubMed ID: 32476105
[TBL] [Abstract][Full Text] [Related]
55. Prognostic Value of
Uusitalo V; Suomalainen O; Loimaala A; Mätzke S; Heliö T
Heart Lung Circ; 2022 May; 31(5):629-637. PubMed ID: 35063379
[TBL] [Abstract][Full Text] [Related]
56. Technetium pyrophosphate uptake in transthyretin cardiac amyloidosis: Associations with echocardiographic disease severity and outcomes.
Vranian MN; Sperry BW; Hanna M; Hachamovitch R; Ikram A; Brunken RC; Jaber WA
J Nucl Cardiol; 2018 Aug; 25(4):1247-1256. PubMed ID: 28050864
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders.
López-Sainz Á; de Haro-Del Moral FJ; Dominguez F; Restrepo-Cordoba A; Amor-Salamanca A; Hernandez-Hernandez A; Ruiz-Guerrero L; Krsnik I; Cobo-Marcos M; Castro V; Toquero-Ramos J; Lara-Pezzi E; Fernandez-Lozano I; Alonso-Pulpon L; González-López E; Garcia-Pavia P
Amyloid; 2019 Sep; 26(3):156-163. PubMed ID: 31210553
[No Abstract] [Full Text] [Related]
58. Reliability and feasibility of visual grading systems and quantitative indexes on [
Bae S; Gil J; Paeng JC; Park EA; Lee SP; Choi H; Kang KW; Cheon GJ; Lee DS
Sci Rep; 2022 Oct; 12(1):17271. PubMed ID: 36241893
[TBL] [Abstract][Full Text] [Related]
59.
Flaherty KR; Morgenstern R; Pozniakoff T; DeLuca A; Castano A; Maurer MS; Bokhari S
J Nucl Cardiol; 2020 Apr; 27(2):371-380. PubMed ID: 31463816
[TBL] [Abstract][Full Text] [Related]
60. Cardiac amyloidosis: updates in diagnosis and management.
Mohty D; Damy T; Cosnay P; Echahidi N; Casset-Senon D; Virot P; Jaccard A
Arch Cardiovasc Dis; 2013 Oct; 106(10):528-40. PubMed ID: 24070600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
